Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welcef TB
Welcef TB (Ceftriaxone & Tazobactam Injection) is a potent antibiotic combination designed to combat severe bacterial infections. It combines the third-generation cephalosporin Ceftriaxone and the β-lactamase inhibitor Tazobactam, providing broad-spectrum antibacterial activity. This combination is highly effective against bacteria resistant to β-lactam antibiotics, ensuring comprehensive treatment for life-threatening infections.
Uses of Welcef TB
Welcef TB is indicated for the treatment of:
Pneumonia (Community-Acquired and Hospital-Acquired)
Intra-Abdominal Infections (e.g., peritonitis, appendicitis)
Urinary Tract Infections (UTIs)
Sepsis (Systemic Inflammatory Response Syndrome)
Bacterial Meningitis
Skin and Soft Tissue Infections
Benefits of Welcef TB
Broad-Spectrum Activity Against a Wide Range of Bacterial Pathogens
Enhanced Effectiveness Against β-lactamase-Producing Bacteria
Effective for Treating Severe and Hospital-Acquired Infections
Rapid Onset of Action in Critical Care Settings
Reduces Risk of Complications in Infected Patients
Mechanism of Action of Welcef TB
Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to bacterial cell lysis. It is effective against a wide range of both gram-positive and gram-negative organisms.
Tazobactam inhibits β-lactamase enzymes, which would normally degrade Ceftriaxone, thus protecting it and enhancing its activity against resistant bacteria.